ABSTRACT: Tssk2, a member of the testis-specific serine/ threonine kinase (TSSK) family, is expressed predominantly in the testis and is crucial for the formation and function of sperm cells in the mouse. Targeted deletion of Tssk1 and Tssk2 in male chimeric mice caused infertility because of haploinsufficiency of the genes.
I nfertility is one of the major health problems that occur in approximately 15% of couples worldwide, and approximately 50% of infertility is due to male factors (de Kretser, 1997; Matzuk and Lamb, 2002) . Although some genetic factors such as numeric and structural chromosomal abnormalities, microdeletions of azoospermia factor region on the Y chromosome, and mutations of a few known spermatogenesis-related genes may contribute to male idiopathic infertility, they account for only 15% of the cases-the majority of genetic causes including gene mutations still remain to be investigated (Foresta et al, 2002) .
Protein phosphorylation is the most common posttranslational protein modification in eukaryotes, and it controls nearly all of the cellular processes, including spermatogenesis, directly or indirectly (Hanks et al, 1988; Sasson-Corsi, 1997) . As a protein kinase family, the testis-specific serine/threonine kinases (TSSKs) may play an important role in spermatogenesis because they are expressed mainly or specifically in the testis. To date, 5 members of the Tssk gene family, including Tssk1, Tssk2, Tssk3, Tssk4, and Tssk6, have been identified in the mouse (Bielke et al, 1994; Kueng et al, 1997; Zuercher et al, 2000; Hao et al, 2004; Chen et al, 2005; Xu et al, 2008b) . Among them, the Tssk3 gene is expressed specifically in the testis of sexually mature mice and functions in differentiated Leydig cells (Zuercher et al, 2000) . Also, the Tssk4 gene is expressed exclusively in the testis and is involved in the early stages of spermatid differentiation (Don and Stelzer, 2002; Chen et al, 2005) . The Tssk6 gene, also known as small serine/threonine kinase, is expressed largely in elongating spermatids and is required for sperm-egg fusion in the mouse (Spiridonov et al, 2005) . Our previously published study showed that some variations in its human homolog gene may be associated with male infertility (Su et al, 2008) .
The mouse Tssk2 gene was first identified in 1997, and it may be functionally redundant to Tssk1 because of their high sequence similarity and the same kinase substrate, testis-specific kinase substrate (Kueng et al, 1997) . In humans, the TSSK2 gene has been mapped to 22q11.21. It consists of only 1 exon encoding a protein of 358 amino acids containing a Ser/Thr protein kinase domain at its N terminus. Previous research revealed that TSSK2 phosphorylates several flagellar proteins in the central apparatus of the sperm axoneme, such as sperm-associated antigen 16L and testis-specific kinase substrate (Hao et al, 2004; Xu et al, 2008a,b; . Because the expression of TSSK2 persists in the flagella of both humans and mice and correlates well with the formation of microtubule structures during spermatogenesis (Xu et al, 2008a) , it has been suggested that TSSK2 may be crucial for spermatid production in both humans and mice. Further, the targeted deletion of Tssk1 and Tssk2 interrupts spermiogenesis and results in the failure of formation of elongated spermatids in male chimeric mice (Xu et al, 2008b) . Therefore, it is reasonable for us to speculate that TSSK2 may be associated with male spermatogenic impairment in humans.
The present study was aimed at investigating the possible relationship between the variations in the TSSK2 gene and idiopathic male infertility. For this investigation, we performed a mutation screening of the gene in 494 infertile patients with azoospermia or severe oligozoospermia and compared the results with those in 357 fertile controls to explore the possible association of the gene with impaired human spermatogenesis.
Materials and Methods

Patients and Controls
All patients and controls participating in this study were genetically unrelated and were recruited from West China Hospital, Sichuan University, Chengdu, China. The 494 patients included 266 infertile men with idiopathic azoospermia and 228 infertile men with severe oligozoospermia (sperm concentration ,5 6 10 6 sperm/ml) aged 23 to 38 years. All of the patients underwent at least 2 semen analyses according to World Health Organization guidelines (1999). To exclude possible chromosomal abnormalities and microdeletions of the azoospermia factor region on the Y chromosome, cytogenetic and corresponding molecular examinations were also performed (Simonim et al, 1999) . The control group consisted of 357 fertile men aged 26 to 45 years who had fathered at least 1 child without any assisted reproductive techniques. All participants in the study were of Han nationality, which makes up more than 90% of the Chinese population; informed consent was obtained from all participants.
Polymerase Chain Reaction Amplification
Genomic DNA was extracted from peripheral blood lymphocytes using standard phenol-chloroform procedures. Four pairs of primers were designed using PRIMER PREMIER 5.0 (Premier Biosoft International, Palo Alto, California) to amplify the TSSK2 gene according to its mRNA sequence (GenBank accession number NM_053006) and its genomic sequence (Table 1) . Polymerase chain reaction (PCR) amplifications were carried out in a total volume of 50 ml containing 0.1 mg of genomic DNA, 10 pmol each primer, 10 pmol dNTPs, 3 units of Taq polymerase (TaKaRa, Shiga, Japan), 1 ml of dimethyl sulfoxide (DMSO), and standard PCR buffer. The PCR profile was predenaturation at 94uC for 5 minutes, followed by 94uC for 30 seconds, 55uC to 60uC for 30 seconds, and 72uC for 40 seconds for 35 cycles, with a final extension at 72uC for 5 minutes. To genotype c.774C.T, mismatch PCR was used to amplify a 126-bp fragment at an annealing temperature of 61.5uC for 15 seconds and create a new recognition site for the restriction endonuclease Tsp 45I. The sequences of primers used were F: 59-GCGTATCCAGAAG-GAGCACCGTGTG-39 and R: 59-GGATCTCATCGATGT-GGAGCCGGTG-39. The annealing temperatures for the amplification of all DNA fragment are also shown in Table 1 . To confirm the presence of specific PCR products, every amplicon was resolved by 1.5% agarose gel electrophoresis.
Denaturing High-Performance Liquid Chromatography Analysis and DNA Sequencing
Mutation screening of the TSSK2 gene was carried out with the automated WAVE 3500HT Nucleic Acid Fragment Analysis System (Transgenomic Inc, Omaha, Nebraska). The WAVEMAKER 4.1 software was used to determine the optimal melting temperatures for the PCR-amplified fragments (Table 1) . Prior to denaturing high-performance liquid chromatography (DHPLC) analysis, the PCR products were denatured at 94uC for 5 minutes and cooled at room temperature over 45 minutes. Then 8 ml of each product was injected into a high-throughput DNASep column and eluted with a linear acetonitrile gradient at a flow rate of 0.9 ml/min. The elution profiles of homozygous fragments were represented as a single peak, and heterozygous fragments showed multiple peaks and/or aberrant-shaped peaks. The heterozygous samples detected by the DHPLC analysis were reamplified and purified using the E.Z.N.A. Gel Extraction Kit (Omega Bio-Tek Inc, Norcross, Georgia) and then sequenced in both directions on an ABI 3100 DNA Sequencer (Applied Biosystems, Foster City, California).
Genotyping
PCR restriction fragment length polymorphism analysis with corresponding restriction endonucleases BglII, NlaIII, Tsp45I, and Sau96I (New England Biolabs, Beverly, Massachusetts) was carried out to genotype the single-nucleotide polymorphisms (SNPs) identified in this study. The products were electrophoresed on a 3% agarose gel and observed with the Gel Doc1000 System (Bio-Rad Laboratories, Hercules, California) after restriction enzyme digestion.
Statistical Analysis
The allele and genotype frequencies of the patient and control groups were calculated by counting. The software HWE was used to evaluate the Hardy-Weinberg equilibrium of the SNPs. Differences in genotypic and allelic frequencies of the SNPs between infertile patients and controls were assessed by the x 2 test using SPSS 11.0 (SPSS Inc, Chicago, Illinois).
Results
By screening the 59-untranslated region, 39-untranslated region, and exon sequence of the TSSK2 gene in 494 infertile men with oligospermia or azoospermia and 357 controls, 4 single-nucleotide transitions, all located in the coding region, were detected and then confirmed by DNA sequencing. They were c.80A.G, c.774C.T, c.839C.T, and c.1026G.A, according to nomenclature recommendations (http://www.hgvs.org/mutnomen). Both c.80A.G and c.839C.T were missense mutations that result in substitution of Lys by Arg and Thr by Met, respectively. The other 2 transitions were synonymous variations.
The frequencies of minor alleles of all 4 transitions were more than 1% in both infertile patients and controls; therefore, the transitions were SNPs and their genotypes were in Hardy-Weinberg equilibrium (Table 2) . At c.80A.G, the frequencies of allele G (P 5 .027; odds ratio (OR) 5 2.515; 95% confidence interval (CI), 1.077-5.868) and the genotype AG (P 5 .026; OR 5 2.553; 95% CI, 1.088-5.993) were significantly greater in patients than in controls. Also, the frequencies of allele T of c.774C.T (P 5 .003; OR 5 1.403; 95% CI, 1.125-1.750) and carriers with allele T (CT + TT) (P , .001; OR 5 1.571; 95% CI, 1.194-2.067) were significantly higher in patients than in controls. However, for the other 2 SNPs, no obvious differences in either allele or genotype frequencies were found between the 2 groups.
Discussion
It has been suggested that many genetic factors may be involved in idiopathic male infertility. However, to date, only a few genetic defects have been confirmed to result in abnormal spermatogenesis (Matzuk and Lamb, 2002) . In recent years, hundreds of candidate genes related to spermatogenesis have been identified in animals with gene-targeting techniques that disrupt specific genes in animal models (Scherthan, 2003) . For humans, mutation screening of these genes in male infertile patients may be the most effective way to investigate the genetic causes of idiopathic male infertility.
Previous researchers have revealed that Tssk2 plays an important role in spermatogenesis in the mouse (Kueng et al, 1997; Hao et al, 2004; Xu et al, 2008a,b; Zhang et al, 2008) . To explore the possible association of its human homolog with male infertility in humans, we performed mutation screening of the TSSK2 gene in a group of Chinese patients with idiopathic infertility. As the result, 4 SNPs, c.80A.G, c.774C.T, c.839C.T, and c.1026G.A, were identified. These SNPs had already been registered in the National Center for Biotechnology Information SNP database, and the frequencies of the minor alleles of c.80A.G, c.774C.T, and c.1026G.A were similar to that reported in SNP database. However the frequency of allele T of c.839C.T was significantly lower than that presented in the database. The c.839C.T and c.1026G.A may be just polymorphisms without obvious disease-related effects because their distributions were similar between patients and controls. In contrast, the frequencies of allele G and genotype AG of the c.80A.G site were significantly higher in the patient group with oligospermia or azoospermia than those in the controls, suggesting that allele G may be a risk factor for the development of idiopathic male infertility. This A.G mutation results in a substitution of Lys by Arg at the 27th amino acid. Analysis with the online software PROSITE (http:// www.expasy.ch/prosite/; Hofmann et al, 1999) revealed that the 18th to 41st amino acids is the ATP-binding domain and the 18th to 26th amino acids is the nucleotide phosphate-binding region of TSSK. These suggest that this substitution is located closely to the nucleotide phosphate-binding site in the ATP-binding region of TSSK2. Therefore, it is reasonable to speculate that the amino acid substitution may influence the activity of TSSK2. Of course, more functional studies are needed to confirm this.
The statistical analysis showed that the allele T of c.774C.T might also be a risk factor for the spermatogenic impairment. Analysis of the possible influence of c.774C.T on the gene expression with Consite (http://asp. ii.uib.no:8090/cgi-bin/CONSITE/consite; Sandelin et al, 2004) showed that the substitution created a consensus sequence (GTCAGTCA), which could be recognized by the transcription factor c-FOS, a member of the FOS family of transcription factors that can be rapidly induced by acute challenges (Harris, 1998; Kovács, 1998) . Therefore, the allele T of c.774C.T may influence the expression level of TSSK2. However, because c-FOS is not constitutively expressed and functions mainly in the central neuron, it is also possible that this SNP is in linkage disequilibrium with some other loci that are associated with idiopathic male infertility.
To our knowledge, the present study is the first systematic mutation analysis of the TSSK2 gene in human infertility with azoospermia or severe oligozoospermia. Our findings indicate that some nucleotide variations in the TSSK2 gene may be associated with impaired spermatogenesis and male infertility. Of course, more studies in different populations, as well as further investigations including functional analysis of the variants, are needed to elucidate the role, mechanisms, and pathology of the TSSK2 gene in human spermatogenesis.
